Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...

Meanwhile, it booked another $2 billion from Xgeva, a higher-dose denosumab-based product used to treat tumours that have spread to the bone, as well as cancer-related hypercalcaemia. "This ...

Scientists at the University of Toronto are developing a groundbreaking treatment that could replace the need for daily eye drops for glaucoma patients with a single injection under the eyelid.

The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient using CRISPR-based gene-editing therapy, Casgevy (exagamglogene autotemcel).

Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that ...

In November, Amneal received FDA approval for exenatide, its first generic injectable glucagon-like peptide-1 (GLP-1) agonist ...

A chemist holds a psilocybin mushroom.Lizzy Acker/The Oregonian A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

When giving gluteal injections, it is safest to use the upper outer quadrant ... The recommended treatment ranges from a conservative approach to immediate operative exposure and irrigation ...

But CPAP compliance and use can be hard for some people due to health problems or the inability to get comfortable and fall asleep using a CPAP mask. Additional problems with CPAP compliance include ...

Unlike many other drugs used to treat diabetes, sitagliptin does not cause weight gain. Animal studies have shown that it can help prevent ß-cell apoptosis and improve ß-cell functioning ...